NCT04058678View on ClinicalTrials.gov

Effects of Telomerase Reactivation With Danazol in Ovarian Function.

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Ovarian Reserve
Interventions
DRUG

Danazol/Placebo

This group will be randomized 1:1 for either inactive substance or Danazol, according to a computer-generated randomization list prepared. Women will be treated with Danazol/Placebo oral way for 3 months.

OTHER

Without intervention

Women with normal ovarian reserve will not be treated in anyway, thus, randomization will not be necessary.

Trial Locations (1)

28023

Ivirma Madrid, Madrid

All Listed Sponsors
lead

IVI Madrid

OTHER

NCT04058678 - Effects of Telomerase Reactivation With Danazol in Ovarian Function. | Biotech Hunter | Biotech Hunter